Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic PerspectiveBODEN, William E; FLATHER, Marcus D; BHATT, Deepak L et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 3, pp 207-216, issn 0920-3206, 10 p.Article

Rates and causes of death from non-ST elevation acute coronary syndromes: Ten year follow-up of the PRAIS-UK registryERDEM, Guliz; BAKHAI, Ameet; TANEJA, Anil K et al.International journal of cardiology. 2013, Vol 168, Num 1, pp 490-494, issn 0167-5273, 5 p.Article

The CAPRIE-like subgroups of CHARISMA : A CAPRIEciously biased analysis of an unCHARISMAtic truth. Authors' replyGEBEL, James M; BHATT, Deepak L; FLATHER, Marcus D et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 17, pp 1704-1705, issn 0735-1097, 2 p.Article

Potential impact of socioeconomic differences on clinical outcomes in international clinical trialsSHIBATA, Marcelo C; FLATHER, Marcus D; PEREZ DE ARENAZA, Diego et al.The American heart journal. 2001, Vol 141, Num 6, pp 1019-1024, issn 0002-8703Article

Radial artery pulse wave analysis for non-invasive assessment of coronary artery diseaseKOTECHA, Dipak; NEW, Gishel; COLLINS, Peter et al.International journal of cardiology. 2013, Vol 167, Num 3, pp 917-924, issn 0167-5273, 8 p.Article

Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trialsKOTECHA, Dipak; NGO, Katherine; WALTERS, Julia A. E et al.The American heart journal. 2011, Vol 161, Num 5, pp 822-831, issn 0002-8703, 10 p.Article

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes : the PREDICT study. CommentaryBUDOFF, Matthew J; ELKELES, Robert S; GODSLAND, Ian F et al.European heart journal. 2008, Vol 29, Num 18, issn 0195-668X, 2193-2194, 2244-2251 [10 p.]Article

Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006FOX, Keith A. A; STEG, Philippe Gabriel; EAGLE, Kim A et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 17, pp 1892-1900, issn 0098-7484, 9 p.Article

Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute Coronary syndromes in the Global Registry of acute Coronary Events (GRACE)STEG, Philippe Gabriel; GOLDBERG, Robert J; GORE, Joel M et al.The American journal of cardiology. 2002, Vol 90, Num 4, pp 358-363, issn 0002-9149Article

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) StudyCONNOLLY, Stuart J; WALLENTIN, Lars; AVEZUM, Alvaro et al.Circulation (New York, N.Y.). 2013, Vol 128, Num 3, pp 237-243, issn 0009-7322, 7 p.Article

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialBHATT, Deepak L; FLATHER, Marcus D; HAMM, Christian W et al.Journal of the American College of Cardiology. 2007, Vol 49, Num 19, pp 1982-1988, issn 0735-1097, 7 p.Article

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease : A meta-analysis of individual patient data from randomized clinical trialsMERCADO, Nestor; WIJNS, William; GERSH, Bernard J et al.Journal of thoracic and cardiovascular surgery. 2005, Vol 130, Num 2, pp 512-519, issn 0022-5223, 8 p.Article

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)FLATHER, Marcus D; SHIBATA, Marcelo C; SOLER-SOLER, Jordi et al.European heart journal. 2005, Vol 26, Num 3, pp 215-225, issn 0195-668X, 11 p.Article

Adherence to evidence-based therapies after discharge for acute coronary syndromes: An ongoing prospective, observational studyEAGLE, Kim A; KLINE-ROGERS, Eva; GOODMAN, Shaun G et al.The American journal of medicine. 2004, Vol 117, Num 2, pp 73-81, issn 0002-9343, 9 p.Article

National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomBAKHAI, Ameet; FLATHER, Marcus D; COLLINSON, Julian R et al.International journal of cardiology. 2003, Vol 91, Num 2-3, pp 163-172, issn 0167-5273, 10 p.Article

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyBHATT, Deepak L; PARE, Guillaume; FLATHER, Marcus D et al.European heart journal. 2012, Vol 33, Num 17, pp 2143-2150, issn 0195-668X, 8 p.Article

Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non―ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS)FLATHER, Marcus D; BABALIS, Daphne; BOJESTIG, Mats et al.The American heart journal. 2011, Vol 162, Num 4, pp 700-707, issn 0002-8703, 8 p.Article

Double-blind, placebo-controlled Phase 11 studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery diseaseGOTO, Shinya; OGAWA, Hisao; TAKEUCHI, Masaru et al.European heart journal. 2010, Vol 31, Num 21, pp 2601-2613, issn 0195-668X, 13 p.Article

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)VAN VELDHUISEN, Dirk J; COHEN-SOLAL, Alain; BÖHM, Michael et al.Journal of the American College of Cardiology. 2009, Vol 53, Num 23, pp 2150-2158, issn 0735-1097, 9 p.Article

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome : prospective multinational observational study (GRACE)FOX, Keith A. A; DABBOUS, Omar H; GRANGER, Christopher B et al.BMJ. British medical journal (International ed.). 2006, Vol 333, Num 7578, pp 1091-1094, issn 0959-8146, 4 p.Article

Darapladib for Preventing Ischemic Events in Stable Coronary Heart DiseaseWHITE, Harvey D; HELD, Claes; ARMSTRONG, Paul W et al.The New England journal of medicine. 2014, Vol 370, Num 18, pp 1702-1711, issn 0028-4793, 10 p.Article

Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease TrialWIVIOTT, Stephen D; FLATHER, Marcus D; ANGIOLILLO, Dominick J et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 17, pp 1854-1863, issn 0009-7322, 10 p.Article

Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes TrialO'DONOGHUE, Michelle L; BHATT, Deepak L; GUETTA, Victor et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 17, pp 1843-1853, issn 0009-7322, 11 p.Article

Change in Serum Lipids after Acute Coronary Syndromes: Secondary Analysis of SPACE ROCKET Study Data and a Comparative Literature ReviewBARTH, Julian H; JACKSON, Beryl M; WHITEHEAD, Andrew et al.Clinical chemistry (Baltimore, Md.). 2010, Vol 56, Num 10, pp 1592-1598, issn 0009-9147, 7 p.Article

Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the prais UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK)TANEJA, Anil K; COLLINSON, Julian; FLATHER, Marcus D et al.European heart journal. 2004, Vol 25, Num 22, pp 2013-2018, issn 0195-668X, 6 p.Article